DEF 14A: Azitra, Inc. Seeks Stockholder Approval for Reverse Stock Split to Maintain NYSE American Listing

Azitra, Inc. is asking stockholders to approve a reverse stock split at its upcoming Special Meeting to maintain its listing on the NYSE American.

Summary

• Azitra, Inc. is holding a Special Meeting of Stockholders on June 27, 2024, to vote on two proposals.
• The first proposal is to approve an amendment to the company's Certificate of Incorporation to effect a reverse stock split of its issued and outstanding shares of common stock.
• The reverse split ratio would range from 1-for-2 to 1-for-30, with the exact ratio to be determined by the Board of Directors.
• The primary purpose of the reverse stock split is to avoid delisting from the NYSE American, as the company's stock price has been trading at levels that could trigger delisting concerns.
• The second proposal is to approve the adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the reverse stock split proposal.
• Stockholders of record as of May 24, 2024, are entitled to vote at the Special Meeting.
• The Board of Directors recommends that stockholders vote in favor of both proposals.

Sentiment

Score: 6

Explanation: The document is neutral in tone, primarily focusing on the procedural aspects of the reverse stock split and its potential benefits and risks. While the company expresses a need to maintain its listing, the document acknowledges the uncertainties associated with the reverse stock split's success.

Positives

• The reverse stock split could increase the market price of Azitra's common stock, potentially improving its marketability and liquidity.
• A higher stock price could allow a broader range of institutions to invest in Azitra, potentially increasing trading volume.
• The reverse stock split could help increase analyst and broker interest in Azitra's common stock.
• The reverse split will result in an effective increase in the authorized number of shares of common stock, allowing the company to issue additional shares in the future without requiring stockholder approval.

Negatives

• There is no guarantee that the reverse stock split will increase the price of Azitra's common stock or ensure continued compliance with NYSE American listing requirements.
• The reverse stock split may decrease the liquidity of Azitra's common stock due to the reduced number of shares outstanding.
• The reverse stock split may result in future dilution to existing stockholders due to the increased number of authorized but unissued shares.

Risks

• The per share price of Azitra's common stock after the reverse split may not rise in proportion to the reduction in the number of shares outstanding.
• The market price per post-reverse split share may not exceed or remain in excess of the NYSE American minimum price for a sustained period of time.
• The reverse split may not result in a per share price that would attract brokers and investors who do not trade in lower-priced stocks.
• Even if the reverse split is implemented, the market price of Azitra's common stock may decrease due to factors unrelated to the reverse split.
• A decline in the market price of Azitra's common stock after the reverse split is implemented may result in a greater percentage decline than would occur in the absence of the reverse split.
• Azitra may be delisted due to a failure to meet other continued listing requirements, including those related to minimum stockholder equity, minimum number of shares in the public float, and minimum market value of the public float.

Future Outlook

The company aims to maintain its listing on the NYSE American and improve its stock's marketability and liquidity through the reverse stock split.

Management Comments

• Francisco D. Salva, President and Chief Executive Officer, urges stockholders to vote their shares.
• The Board strongly believes that the Reverse Split is necessary to maintain our listing on the NYSE American.

Industry Context

Reverse stock splits are a common strategy for companies facing delisting from major exchanges due to low stock prices. This action aims to increase the stock price to meet minimum listing requirements and potentially attract a broader range of investors.

Comparison to Industry Standards

• Many small-cap biotech companies facing similar stock price challenges have implemented reverse stock splits to maintain exchange listings.
• Comparable companies that have recently undertaken reverse stock splits include [hypothetical company A] and [hypothetical company B].
• The success of a reverse stock split in maintaining listing and improving stock performance varies widely and depends on the company's underlying fundamentals and market conditions.

Stakeholder Impact

• The reverse stock split could impact shareholders by changing the number of shares they own and potentially affecting the stock's market price and liquidity.
• Employees may be affected if the company's listing status is impacted, as it could influence employee morale and stock option values.
• Customers and suppliers may experience minimal direct impact, but the company's financial stability and long-term viability could be indirectly affected.

Next Steps

• Stockholders will vote on the proposals at the Special Meeting on June 27, 2024.
• If approved, the Board will determine the final reverse split ratio and announce it publicly.
• The company will file the Reverse Split Amendment with the Secretary of State of the State of Delaware to effect the reverse split.

Key Dates

Keywords

reverse stock split, proxy statement, NYSE American, delisting, common stock, stockholders, Azitra